Chimonanthus nitens var. salicifolius aqueous extract protects against 5-fluorouracil induced gastrointestinal mucositis in a mouse model

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Liu, Zhenze ^a   Xi, Jun ^b   Schröder, Sven ^c   Wang, Weigang ^b   Xie, Tianpei ^d   Wang, Zhugang ^b   Bao, Shisan ^a,e   Fei, Jian ^a,b  

^a TONGJI UNIVERSITY   (China)

^b Shanghai Research Center for Model Organisms   (China)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Shanghai Fuchun Kexin Biotech Co Ltd   (China)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893729880     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/789263     Document Type: Article

References (53)

1. Hu C. Y., Xiao W. F., Biological characteristic sand cultivation techniques of Chimonanthus salicifolius. Forest by-Product and Speciality in China 2005 76 5 6
2. Hu C. Y., Tang X. Y., Analysis of nutritious components in leaves of wild Chimonanthus salicifolius. Journal of Huangshan University 2007 9 91 93
3. Wang L. Y., Zhang Z. D., Zou Z. R., Advances of studies on chemical composition and pharmacological activity of Chimonanthus lindl. Lishizhen Medicine and Materia Medica Research 2012 23 3103 3106
4. Fang J. X., Cheng G. D., On the characters of Chimonanthus salicifolius and its distribution and utilization in huangshan region. Journal of Anhui Agricultural Sciences 2009 37 1530 1531
5. Mitchell E. P., Gastrointestinal toxicity of chemotherapeutic agents. Seminars in Oncology 2006 33 1 106 120 2-s2.0-32244436980 10.1053/j.seminoncol. 2005.12.001 (Pubitemid 43214491)
6. Cool J. C., Dyer J. L., Xian C. J., Butler R. N., Geier M. S., Howarth G. S., Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Hormone and IGF Research 2005 15 1 72 82 2-s2.0-13544258900 10.1016/j.ghir.2004.12.002 (Pubitemid 40220858)
7. Davila M., Bresalier R. S., Gastrointestinal complications of oncologic therapy. Nature Clinical Practice Gastroenterology and Hepatology 2008 5 12 682 696 2-s2.0-57049159806 10.1038/ncpgasthep1277
8. Keefe D. M. K., Gastrointestinal mucositis: a new biological model. Supportive Care in Cancer 2004 12 1 6 9 2-s2.0-1642553346 10.1007/s00520-003- 0550-9 (Pubitemid 38133504)
9. Keefe D. M., Peterson D. E., Schubert M. M., Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls. Supportive Care in Cancer 2006 14 6 492 498 2-s2.0-33746036534 10.1007/s00520-006-0059-0
10. Saegusa Y., Ichikawa T., Iwai T., Goso Y., Okayasu I., Ikezawa T., Shikama N., Saigenji K., Ishihara K., Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scandinavian Journal of Gastroenterology 2008 43 1 59 65 2-s2.0-37549072675 10.1080/00365520701579662
11. Sonis S. T., The pathobiology of mucositis. Nature Reviews Cancer 2004 4 4 277 284 2-s2.0-1942469964 (Pubitemid 38525283)
12. Keefe D. M. K., Mucositis guidelines: what have they achieved, and where to from here? Supportive Care in Cancer 2006 14 6 489 491 2-s2.0-33745210599 10.1007/s00520-006-0056-3
13. Bowen J. M., Gibson R. J., Keefe D. M. K., Animal models of mucositis: implications for therapy. Journal of Supportive Oncology 2011 9 5 161 168 2-s2.0-82855163917 10.1016/j.suponc.2011.04.009
14. Sonis S. T., New thoughts on the initiation of mucositis. Oral Diseases 2010 16 7 597 600 2-s2.0-77956853059 10.1111/j.1601-0825.2010.01681.x
15. Huang T.-Y., Chu H.-C., Lin Y.-L., Ho W.-H., Hou H.-S., Chao Y.-C., Liao C.-L., Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model. Biochemical and Biophysical Research Communications 2009 389 4 634 639 2-s2.0-70349731911 10.1016/j.bbrc.2009.09.041
16. Sonis S. T., Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology 2009 45 12 1015 1020 2-s2.0-70449525211 10.1016/j.oraloncology.2009.08.006
17. Keefe D. M., Sonis S. T., Bowen J. M., Emerging drugs for chemotherapy-induced mucositis. Expert Opinion on Emerging Drugs 2008 13 3 511 522 2-s2.0-53649097452 10.1517/14728214.13.3.511
18. Lam W., Bussom S., Guan F., Jiang Z., Zhang W., Gullen E. A., Liu S.-H., Cheng Y.-C., Chemotherapy: the four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Science Translational Medicine 2010 2 45, article 45ra59 2-s2.0-77955898834 10.1126/scitranslmed.3001270
19. Wen H., Fei J., Tong Y., A pilot study on the anti-diarrheal effect of Chimonanthus salicifolius. Jingxi Journal of Traditional Chinese Medicine 2012 43 62 63
20. Alimonti A., Gelibter A., Pavese I., Satta F., Cognetti F., Ferretti G., Rasio D., Vecchione A., Di Palma M., New approaches to prevent intestinal toxicity of irinotecan-based regimens. Cancer Treatment Reviews 2004 30 6 555 562 2-s2.0-4444241175 10.1016/j.ctrv.2004.05.002 (Pubitemid 39161879)
21. Letari O., Booth C., Bonazzi A., Garofalo P., Makovec F., Rovati L. C., Caselli G., Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice. Cancer Chemotherapy and Pharmacology 2010 66 5 819 827 2-s2.0-77956228663 10.1007/s00280-009-1224-1
22. Bao S., Carr E. D. J., Xu Y.-H., Hunt N. H., Gp91 phox contributes to the development of experimental inflammatory bowel disease. Immunology and Cell Biology 2011 89 8 853 860 2-s2.0-80855128740 10.1038/icb.2011.4
23. Tavakoli N. N., Harris A. K., Sullivan D. R., Hambly B. D., Bao S., Interferon-gamma deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet. International Journal of Molecular Medicine 2012 30 545 552
24. Gibson R. J., Keefe D. M. K., Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Supportive Care in Cancer 2006 14 9 890 900 2-s2.0-33747364771 10.1007/s00520-006-0040-y
25. Gibson R. J., Stringer A. M., Chemotherapy-induced diarrhoea. Current Opinion in Supportive and Palliative Care 2009 3 1 31 35 2-s2.0-67650302499 10.1097/SPC.0b013e32832531bb
26. Farrell C. L., Bready J. V., Rex K. L., Chen J. N., DiPalma C. R., Whitcomb K. L., Yin S., Hill D. C., Wiemann B., Starnes C. O., Havill A. M., Lu Z.-N., Aukerman S. L., Pierce G. F., Thomason A., Potten C. S., Ulich T. R., Lacey D. L., Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Research 1998 58 5 933 939 2-s2.0-0032030965 (Pubitemid 28182461)
27. An F., Gong B., Wang H., Yu D., Zhao G., Lin L., Tang W., Yu H., Bao S., Xie Q., miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis 2012 17 7 702 716 2-s2.0-84857379482 10.1007/s10495-012-0704-7
28. Xu Y., Wang H., Bao S., Tabassam F., Cai W., Amelioration of liver injury by continuously targeted intervention against TNFRp55 in rats with acute-on-chronic liver failure. PLoS One 2013 8 e68757
29. Lindsay R. J., Geier M. S., Yazbeck R., Butler R. N., Howarth G. S., Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis. British Journal of Nutrition 2010 104 4 513 519 2-s2.0-77956209758 10.1017/S000711451000084X
30. Melo M. L. P., Brito G. A. C., Soares R. C., Carvalho S. B. L. M., Silva J. V., Soares P. M. G., Vale M. L., Souza M. H. L. P., Cunha F. Q., Ribeiro R. A., Role of cytokines (TNF- α IL-1 β and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Cancer Chemotherapy and Pharmacology 2008 61 5 775 784 2-s2.0-39749129032 10.1007/s00280-007-0534-4 (Pubitemid 351302033)
31. Nonzee N. J., Dandade N. A., Markossian T., Agulnik M., Argiris A., Patel J. D., Kern R. C., Munshi H. G., Calhoun E. A., Bennett C. L., Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis: results from a Northwestern university costs of cancer program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a veterans administration hospital, or a comprehensive cancer care center. Cancer 2008 113 6 1446 1452 2-s2.0-67649213022 10.1002/cncr.24097
32. Rolston K. V. I., Elting L. S., Cantor S. B., Rubenstein E. B., The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2004 100 6 1324 1326 2-s2.0-1542284089 10.1002/cncr.20101 (Pubitemid 38325962)
33. Farrell C. L., Rex K. L., Chen J. N., Bready J. V., DiPalma C. R., Kaufman S. A., Rattan A., Scully S., Lacey D. L., The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Proliferation 2002 35 supplement 1 78 85 2-s2.0-0036360966 10.1046/j.1365-2184.35.s1.8.x (Pubitemid 34985150)
34. Kiliç Y., Rajewski K., Dörr W., Effect of post-exposure administration of keratinocyte growth factor (Palifermin) on radiation effects in oral mucosa in mice. Radiation and Environmental Biophysics 2007 46 1 13 19 2-s2.0-33847625886 10.1007/s00411-006-0079-7 (Pubitemid 46354800)
35. Gibson R. J., Keefe D. M. K., Thompson F. M., Clarke J. M., Goland G. J., Cummins A. G., Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Digestive Diseases and Sciences 2002 47 12 2751 2757 2-s2.0-0036907234 10.1023/A:1021061306913 (Pubitemid 35471617)
36. Sun J., Wang H., Hu H., Glutamine for chemotherapy induced diarrhea: a meta-analysis. Asia Pacific Journal of Clinical Nutrition 2012 21 380 385
37. Farrell M. P., Kummar S., Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer. Clinical Colorectal Cancer 2003 2 4 253 256 2-s2.0-0037302385 (Pubitemid 36367315)
38. Prasetyo J., Naruse K., Kato T., Boonchird C., Harashima S., Park E. Y., Bioconversion of paper sludge to biofuel by simultaneous saccharification and fermentation using a cellulase of paper sludge origin and thermotolerant saccharomyces cerevisiae TJ14. Biotechnology for Biofuels 2011 4, article 35 2-s2.0-80054843009 10.1186/1754-6834-4-35
39. Wright T. H., Yazbeck R., Lymn K. A., Whitford E. J., Cheah K. Y., Butler R. N., Feinle-Bisset C., Pilichiewicz A. N., Mashtoub S., Howarth G. S., The herbal extract, Iberogast, improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis. Cancer Biology and Therapy 2009 8 10 923 929 2-s2.0-68049137889
40. Saltz L. B., Understanding and managing chemotherapy-induced diarrhea. The Journal of Supportive Oncology 2003 1 1 35 38 2-s2.0-4544368057
41. Stern J., Ippoliti C., Management of acute cancer treatment-induced diarrhea. Seminars in Oncology Nursing 2003 19 3 11 16 2-s2.0-1842538074 10.1053/j.soncn.2003.09.009 (Pubitemid 40434439)
42. Benson A. B. III, Ajani J. A., Catalano R. B., Engelking C., Kornblan S. M., Martenson J. A. Jr., McCallum R., Mitchell E. P., O'Dorisio T. M., Vokes E. E., Wadler S., Recommended guidelines for the treatment of cancer treatment-induced diarrhea. Journal of Clinical Oncology 2004 22 14 2918 2926 2-s2.0-4344708355 10.1200/JCO.2004.04.132 (Pubitemid 41079912)
43. Bowen J. M., Keefe D. M., New pathways for alimentary mucositis. Journal of Oncology 2008 2008 7 907892 10.1155/2008/907892
44. Sonis S. T., Regimen-related gastrointestinal toxicities in cancer patients. Current Opinion in Supportive and Palliative Care 2010 4 1 26 30 2-s2.0-77950353795 10.1097/SPC.0b013e328335fb76
45. Arjumand W., Seth A., Sultana S., Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NF B, TNF- α and caspase-3 expression in wistar rats. Food and Chemical Toxicology 2011 49 9 2013 2021 2-s2.0-79960843843 10.1016/j.fct.2011.05.012
46. Gong G., Qin Y., Huang W., Zhou S., Yang X., Li D., Rutin inhibits hydrogen peroxide-induced apoptosis through regulating reactive oxygen species mediated mitochondrial dysfunction pathway in human umbilical vein endothelial cells. European Journal of Pharmacology 2010 628 1-3 27 35 2-s2.0-73849096161 10.1016/j.ejphar.2009.11.028
47. Calderon-Montano J. M., Burgos-Moron E., Perez-Guerrero C., Lopez-Lazaro M., A review on the dietary flavonoid kaempferol. Mini Reviews in Medicinal Chemistry 2011 11 298 344
48. Formica J. V., Review of the biology of quercetin and related bioflavonoids. Food and Chemical Toxicology 1995 33 12 1061 1080 2-s2.0-0029610477 10.1016/0278-6915(95)00077-1 (Pubitemid 26009773)
49. Suzuki T., Tanabe S., Hara H., Kaempferol enhances intestinal barrier function through the cytoskeletal association and expression of tight junction proteins in Caco-2 cells 1-3. Journal of Nutrition 2011 141 1 87 94 2-s2.0-78650452784 10.3945/jn.110.125633
50. Heggie G. D., Sommadossi J.-P., Cross D. S., Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Research 1987 47 8 2203 2206 2-s2.0-0023187085 (Pubitemid 17074634)
51. Milano G., Chamorey A.-L., Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics. Chronobiology International 2002 19 1 177 189 2-s2.0-0036223408 10.1081/CBI-120002597 (Pubitemid 34310826)
52. Block K. I., Gyllenhaal C., Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Integrative Cancer Therapies 2002 1 1 83 89 2-s2.0-0041761331 10.1177/1534735402001001007 (Pubitemid 37101542)
53. Taketo M. M., Mouse models of gastrointestinal tumors. Cancer Science 2006 97 5 355 361 2-s2.0-33645535554 10.1111/j.1349-7006.2006.00190.x